During the past decade, Hospital Tunku Azizah Kuala Lumpur conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Tunku Azizah Kuala Lumpur" are "Genetic Diseases, Inborn" (1 trials), "Genetic Diseases, X-Linked" (1 trials), "Hemophilia A With Inhibitor" (1 trials), "Hemophilia B With Inhibitor" (1 trials) and "Muscular Diseases" (1 trials). Many other conditions were trialed in "Hospital Tunku Azizah Kuala Lumpur" in a lesser frequency.

Most popular intervention types in "Hospital Tunku Azizah Kuala Lumpur" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ataluren" (1 trials), "MarzAA" (1 trials) and "PLACEBO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Tunku Azizah Kuala Lumpur" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Tunku Azizah Kuala Lumpur". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital Tunku Azizah Kuala Lumpur, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Tunku Azizah Kuala Lumpur, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".